Search for: "Bartlett v. Mutual Pharmaceutical Company" Results 1 - 20 of 48
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jul 2013, 5:00 am by Bexis
  The subject is preemption – specifically the the United States Supreme Court’s recent ruling in Mutual Pharmaceutical Company, Inc. v. [read post]
1 Jul 2013, 10:16 am by Ronald Mann
(Photo by Sarah Macmillan/Creative Commons) The smoke finally cleared last Monday in Mutual Pharmaceutical Co. v. [read post]
19 Mar 2013, 6:58 am by Bexis
Bartlett – that is to say Mutual Pharmacy Co. v. [read post]
7 May 2012, 5:00 am by Bexis
Mutual Pharmaceutical Co., ___ F.3d ___, 2012 WL 1522004 (1st Cir. [read post]
16 Aug 2010, 4:30 am by Mary Giorgi
Bartlett's pharmacist filled per prescription with Sulindac, the generic version of Clinoril, manufactured by Mutual Pharmaceutical Company ("Mutual"). [read post]
23 Aug 2013, 3:27 am by Jon Gelman
Extending the monopolies of brand-name companies in this way reportedly costs consumers more than $3.5 billion per year.2 Since such settlements suppress competition, the Court sent the case back to the district court to be evaluated according to the “rule of reason,” one of the standards for determining whether an action violates antitrust law.Second, in Mutual Pharmaceutical v. [read post]
2 Aug 2012, 10:17 am by FDABlog HPM
May 2, 2012) denying Mutual Pharmaceutical Company’s (“Mutual’s”) appeal of a decision from the U.S. [read post]
5 Jun 2013, 9:34 am
SUPREME COURT Today, both the makers or dangerous pharmaceuticals and the lawyers who sue them on behalf of those who are harmed by such drugs are closely watching and nervously waiting for the United States Supreme Court to release its opinion in the case of Karen Bartlett of New Hampshire, who is suing the Mutual Pharmaceutical Company. [read post]
4 May 2012, 4:07 am by Brian Wolfman
Mutual Pharmaceutical Company, the First Circuit has parsed Wyeth and PLIVA and held that the defective-design claim is not preempted. [read post]
2 Dec 2012, 9:57 pm by Brian Wolfman
Last Friday, the Supreme Court granted review in Mutual Pharmaceutical Co. v. [read post]
31 Mar 2016, 3:00 am
The second paragraph cites the key sentence from Mutual Pharmaceutical Co. v. [read post]
19 Mar 2013, 6:01 am by Joe Consumer
  In its argument, Mutual Pharmaceutical is relying on the recent Supreme Court case, Pliva v Mensing where the Court held that generic drug manufacturers can’t be held responsible for failing to warn patients about a drug’s side effects. [read post]